Molecular Aspects of Plasmodium falciparum Infection during Pregnancy

Cytoadherence of Plasmodium-falciparum-parasitized red blood cells (PRBCs) to host receptors is the key phenomenon in the pathological process of the malaria disease. Some of these interactions can originate poor outcomes responsible for...

Full description

Bibliographic Details
Main Authors: Nicaise Tuikue Ndam, Philippe Deloron
Format: Article
Language:English
Published: Hindawi Limited 2007-01-01
Series:Journal of Biomedicine and Biotechnology
Online Access:http://dx.doi.org/10.1155/2007/43785
id doaj-36bf4c409aa9492e83db8de1ad88ee65
record_format Article
spelling doaj-36bf4c409aa9492e83db8de1ad88ee652020-11-25T00:16:04ZengHindawi LimitedJournal of Biomedicine and Biotechnology1110-72431110-72512007-01-01200710.1155/2007/4378543785Molecular Aspects of Plasmodium falciparum Infection during PregnancyNicaise Tuikue Ndam0Philippe Deloron1UR 010, Laboratoire de Parasitologie, Institut de Recherche pour le Développement, Université Paris Descartes, IFR 71, 4 avenue de l'Observatoire, Paris 75006, FranceUR 010, Laboratoire de Parasitologie, Institut de Recherche pour le Développement, Université Paris Descartes, IFR 71, 4 avenue de l'Observatoire, Paris 75006, FranceCytoadherence of Plasmodium-falciparum-parasitized red blood cells (PRBCs) to host receptors is the key phenomenon in the pathological process of the malaria disease. Some of these interactions can originate poor outcomes responsible for 1 to 3 million annual deaths mostly occurring among children in sub-Saharan Africa. Pregnancy-associated malaria (PAM) represents an important exception of the disease occurring at adulthood in malaria endemic settings. Consequences of this are shared between the mother (maternal anemia) and the baby (low birth weight and infant mortality). Demonstrating that parasites causing PAM express specific variant surface antigens (VSAPAM), including the P. falciparum erythrocyte membrane protein 1 (PfEMP1) variant VAR2CSA, that are targets for protective immunity has strengthened the possibility for the development of PAM-specific vaccine. In this paper, we review the molecular basis of malaria pathogenesis attributable to the erythrocyte stages of the parasites, and findings supporting potential anti-PAM vaccine components evidenced in PAM.http://dx.doi.org/10.1155/2007/43785
collection DOAJ
language English
format Article
sources DOAJ
author Nicaise Tuikue Ndam
Philippe Deloron
spellingShingle Nicaise Tuikue Ndam
Philippe Deloron
Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
Journal of Biomedicine and Biotechnology
author_facet Nicaise Tuikue Ndam
Philippe Deloron
author_sort Nicaise Tuikue Ndam
title Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
title_short Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
title_full Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
title_fullStr Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
title_full_unstemmed Molecular Aspects of Plasmodium falciparum Infection during Pregnancy
title_sort molecular aspects of plasmodium falciparum infection during pregnancy
publisher Hindawi Limited
series Journal of Biomedicine and Biotechnology
issn 1110-7243
1110-7251
publishDate 2007-01-01
description Cytoadherence of Plasmodium-falciparum-parasitized red blood cells (PRBCs) to host receptors is the key phenomenon in the pathological process of the malaria disease. Some of these interactions can originate poor outcomes responsible for 1 to 3 million annual deaths mostly occurring among children in sub-Saharan Africa. Pregnancy-associated malaria (PAM) represents an important exception of the disease occurring at adulthood in malaria endemic settings. Consequences of this are shared between the mother (maternal anemia) and the baby (low birth weight and infant mortality). Demonstrating that parasites causing PAM express specific variant surface antigens (VSAPAM), including the P. falciparum erythrocyte membrane protein 1 (PfEMP1) variant VAR2CSA, that are targets for protective immunity has strengthened the possibility for the development of PAM-specific vaccine. In this paper, we review the molecular basis of malaria pathogenesis attributable to the erythrocyte stages of the parasites, and findings supporting potential anti-PAM vaccine components evidenced in PAM.
url http://dx.doi.org/10.1155/2007/43785
work_keys_str_mv AT nicaisetuikuendam molecularaspectsofplasmodiumfalciparuminfectionduringpregnancy
AT philippedeloron molecularaspectsofplasmodiumfalciparuminfectionduringpregnancy
_version_ 1725384940200132608